New shot could help control bleeding in severe hemophilia a
NCT ID NCT06703606
First seen Apr 03, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study tests a new medicine called marstacimab in people with severe hemophilia A who have been on another medicine (emicizumab) for at least 6 months. The goal is to see if switching to marstacimab is safe and how it works in the body. About 15 teens and adults aged 12 to 75 will receive weekly injections for 4 months. The results will help doctors guide patients who want to change their preventive treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ege University Faculty of Medicine Dean's Office
RECRUITINGBornova, İzmir, 35100, Turkey (Türkiye)
-
K J Somaiya Hospital & Research Centre
RECRUITINGMumbai, Maharashtra, 400022, India
-
Nirmal Hospital Pvt Ltd.
RECRUITINGSurat, Gujarat, 395002, India
-
Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center
RECRUITINGLos Angeles, California, 90007, United States
Conditions
Explore the condition pages connected to this study.